Sean Wieland
Stock Analyst at Piper Sandler
(1.78)
# 3,284
Out of 4,966 analysts
31
Total ratings
45.45%
Success rate
0.21%
Average return
Main Sectors:
Stocks Rated by Sean Wieland
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OMCL Omnicell | Maintains: Overweight | $57 → $55 | $32.59 | +68.76% | 12 | Aug 11, 2025 | |
| PRVA Privia Health Group | Maintains: Overweight | $35 → $36 | $23.04 | +56.25% | 3 | Aug 11, 2025 | |
| AMWL American Well | Maintains: Overweight | $100 → $120 | $6.90 | +1,639.13% | 2 | Jun 23, 2022 | |
| HIMS Hims & Hers Health | Maintains: Overweight | $8 → $6 | $42.35 | -85.83% | 3 | May 26, 2022 | |
| DOCS Doximity | Maintains: Overweight | $81 → $44 | $67.94 | -35.24% | 2 | May 19, 2022 | |
| IQV IQVIA Holdings | Maintains: Neutral | $261 → $231 | $190.81 | +21.06% | 4 | Feb 18, 2022 | |
| TDOC Teladoc Health | Maintains: Overweight | $305 → $291 | $7.73 | +3,664.55% | 5 | Feb 25, 2021 |
Omnicell
Aug 11, 2025
Maintains: Overweight
Price Target: $57 → $55
Current: $32.59
Upside: +68.76%
Privia Health Group
Aug 11, 2025
Maintains: Overweight
Price Target: $35 → $36
Current: $23.04
Upside: +56.25%
American Well
Jun 23, 2022
Maintains: Overweight
Price Target: $100 → $120
Current: $6.90
Upside: +1,639.13%
Hims & Hers Health
May 26, 2022
Maintains: Overweight
Price Target: $8 → $6
Current: $42.35
Upside: -85.83%
Doximity
May 19, 2022
Maintains: Overweight
Price Target: $81 → $44
Current: $67.94
Upside: -35.24%
IQVIA Holdings
Feb 18, 2022
Maintains: Neutral
Price Target: $261 → $231
Current: $190.81
Upside: +21.06%
Teladoc Health
Feb 25, 2021
Maintains: Overweight
Price Target: $305 → $291
Current: $7.73
Upside: +3,664.55%